| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.41B | 3.41B | 3.55B | 3.55B | 3.92B | 4.92B |
| Gross Profit | 1.04B | 1.06B | 850.50M | 657.30M | 872.90M | 1.47B |
| EBITDA | 425.60M | 425.50M | 215.80M | -182.70M | -334.80M | 849.80M |
| Net Income | 145.30M | 145.20M | -34.90M | -380.10M | -437.50M | 512.50M |
Balance Sheet | ||||||
| Total Assets | 2.74B | 2.74B | 2.87B | 3.41B | 4.30B | 4.80B |
| Cash, Cash Equivalents and Short-Term Investments | 36.60M | 36.60M | 71.60M | 31.90M | 86.80M | 244.10M |
| Total Debt | 2.11B | 2.11B | 2.52B | 2.91B | 3.27B | 2.60B |
| Total Liabilities | 3.10B | 3.10B | 3.26B | 3.68B | 4.15B | 3.79B |
| Stockholders Equity | -357.50M | -357.50M | -390.60M | -267.30M | 147.70M | 1.01B |
Cash Flow | ||||||
| Free Cash Flow | 273.90M | 273.90M | 583.50M | 438.20M | -242.50M | 164.60M |
| Operating Cash Flow | 371.30M | 371.30M | 667.50M | 531.00M | -129.00M | 271.50M |
| Investing Cash Flow | -112.10M | -112.10M | -100.40M | -65.70M | -283.20M | -538.60M |
| Financing Cash Flow | -294.00M | -294.00M | -527.90M | -520.10M | 255.30M | 494.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $12.45B | 9.62 | 27.46% | 2.51% | 12.59% | 31.40% | |
65 Neutral | $7.77B | 6.35 | 10.00% | 3.55% | 3.82% | 239.39% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | $7.36B | 20.04 | 6.15% | 3.12% | 1.77% | -8.72% | |
54 Neutral | $3.28B | 22.89 | ― | 4.63% | -3.93% | ― | |
50 Neutral | $4.83M | -0.64 | -64.08% | ― | -1.80% | 15.74% | |
48 Neutral | $1.79B | ― | -11.52% | 16.76% | -13.42% | -136.59% |
On November 21, 2025, The Scotts Miracle-Gro Company entered into a Seventh Amended and Restated Credit Agreement, securing $2.0 billion in senior secured loan facilities, which includes a $1.5 billion revolving credit facility and a $500 million term loan. This agreement replaces the previous Sixth Amended and Restated Credit Agreement, which had a total of $2.5 billion in loan facilities, indicating a strategic financial restructuring to enhance the company’s financial flexibility.
The most recent analyst rating on (SMG) stock is a Buy with a $70.00 price target. To see the full list of analyst forecasts on Scotts Miracle-Gro Company stock, see the SMG Stock Forecast page.
On November 13, 2025, Scotts Miracle-Gro Company will implement a new form of restricted stock unit award notice for certain employees, including executive officers, as part of its Long-Term Incentive Plan. This change is expected to impact the company’s compensation strategy and could influence its ability to attract and retain key talent, thereby affecting its competitive positioning in the industry.
The most recent analyst rating on (SMG) stock is a Buy with a $70.00 price target. To see the full list of analyst forecasts on Scotts Miracle-Gro Company stock, see the SMG Stock Forecast page.
The recent earnings call for Scotts Miracle-Gro highlighted a robust fiscal ’25 performance, marked by significant improvements in gross margin, free cash flow, and brand growth. While the company showcased strong financial results, challenges persist, particularly in commodity product profitability and anticipated sales shifts due to retailer inventory adjustments. Despite these hurdles, the outlook for fiscal ’26 remains optimistic, with confidence in continued growth and strategic initiatives.
The Scotts Miracle-Gro Company is a leading marketer of branded consumer lawn and garden products in North America, known for its well-recognized brands such as Scotts, Miracle-Gro, Ortho, and Tomcat.
On August 28, 2025, The Scotts Miracle-Gro Company amended its Master Receivables Purchase Agreement with JPMorgan Chase Bank to extend the purchase termination date to September 1, 2026. This amendment allows the company to sell up to $750 million in customer accounts receivable, which will continue to be serviced by the company for a fee, and the proceeds will be used for general corporate purposes.
The most recent analyst rating on (SMG) stock is a Hold with a $62.00 price target. To see the full list of analyst forecasts on Scotts Miracle-Gro Company stock, see the SMG Stock Forecast page.